We noticed that PiHL activation could repress cell apoptosis induced by 5-FU in both p53 wild-type and knockout CRC cells, prompting us to further explore PiHL’s potential role in drug resistance and its mechanisms other than p53 regulation. The gene discussed is PCAT1; the disease is colorectal carcinoma.